Latest Articles

Subject

Review
Toward Precision Phenotyping of Multiple Sclerosis
David Pitt, Chih Hung Lo, Susan A. Gauthier, et al.

August 30, 2022
Research Article
Updated Results of the COVID-19 in MS Global Data Sharing InitiativeAnti-CD20 and Other Risk Factors Associated With COVID-19 Severity
Steve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, et al.

August 29, 2022
Research Article
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis
Jason R. Thonhoff, James D. Berry, Eric A. Macklin, et al.

August 29, 2022
Correction
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod
August 26, 2022
RESEARCH ARTICLE
GABA-A Receptor Encephalitis After Autologous Hematopoietic Stem Cell Transplant forMultiple MyelomaThree Cases and Literature Review
Yoji Hoshina, Jonathan Galli, Ka-Ho Wong, et al.

August 26, 2022
Research Article
IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy
Alexandre Jentzer, Arthur Attal, Clémence Roué, et al.

August 10, 2022
RESEARCH ARTICLE
Cerebellar Ataxia With Anti-DNER AntibodiesOutcomes and Immunologic Features
Elise Peter, Le Duy Do, Salem Hannoun, et al.

August 08, 2022
Correction
Heterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia Gravis
August 03, 2022
Research Article
Rituximab-Induced Hypogammaglobulinemia and Risk of Infection in Neuromyelitis Optica Spectrum DisordersA 14-Year Real-Life Experience
Su-Hyun Kim, Na Young Park, Ki Hoon Kim, et al.

July 19, 2022
Research Article
Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis
Rikke Holm Hansen, Jacob Talbot, Helene Højsgaard Chow, et al.

July 14, 2022

Pages